BioCentury
ARTICLE | Distillery Therapeutics

RvD2 for Duchenne muscular dystrophy

December 3, 2021 5:38 PM UTC

DISEASE CATEGORY: Musculoskeletal

INDICATION: Muscular dystrophy...

BCIQ Company Profiles

University of Montreal

BCIQ Target Profiles

Resolvin D2 (RvD2)